Insulin makers, PBMs’ ‘quid pro quo’ targeted by Florida AG antitrust suit
Major insulin manufacturers and pharmacy benefit managers have engaged in an unlawful ‘quid pro quo’ that sent prices skyrocketing between 2011 and 2023, according to a lawsuit filed by Florida Attorney...To view the full article, register now.
Already a subscriber? Click here to view full article